Bruna P. P. Do Nascimento

Bruna P. P. Do Nascimento

Auto-generated profile, based on publicly available information

Bruna P. P. Do Nascimento

Programa de Pós-Graduação em Distúrbios do Desenvolvimento, Centro de Ciências Biológicas e da Saúde Universidade Presbiteriana Mackenzie, São Paulo 01302-907, SP, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2021 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
FLFernanda B. Lorena
Fernanda B. Lorena
BNBruna P. P Do Nascimento
Bruna P. P Do Nascimento
ECEsther L. R. A. Camargo
Esther L. R. A. Camargo
MBMaria M. Bernardi
Maria M. Bernardi
AFAndré Fukushima
André Fukushima
MRMiriam O Ribeiro
Miriam O Ribeiro
Objective: Obesity is characterized by a state of chronic, low-intensity systemic inflammation frequently associated with insulin resistance and dyslipidemia. Materials and methods: Given that chronic inflammation has been implicated in the pathogenesis of mood disorders, we investigated if chronic obesity that was initiated early in life – lasting through adulthood – could be more harmful to memory impairment and mood fluctuations such as depression. Results: Here we show that pre-pubertal male rats (30 days old) treated with a high-fat [...] ABSTRACT Objective: Obesity is characterized by a state of chronic, low-intensity systemic inflammation frequently associated with insulin resistance and dyslipidemia. Materials and methods: Given that chronic inflammation has been implicated in the pathogenesis of mood disorders, we investigated if chronic obesity that was initiated early in life – lasting through adulthood – could be more harmful to memory impairment and mood fluctuations such as depression. Results: Here we show that pre-pubertal male rats (30 days old) treated with a high-fat

Verified
Journal Article
Open access
PDF file
TRThaís Terpins Ravache
Thaís Terpins Ravache
ABAlice Batistuzzo
Alice Batistuzzo
GNGabriela G. Nunes
Gabriela G. Nunes
TGThiago G. B. Gomez
Thiago G. B. Gomez
FLFernanda B. Lorena
Fernanda B. Lorena
MRMiriam O Ribeiro
Miriam O Ribeiro
Norepinephrine plays an important role in modulating memory through its beta-adrenergic receptors (Adrβ: β1, β2 and β3). Here, we hypothesized that multisensory stimulation would reverse memory impairment caused by the inactivation of Adrβ3 (Adrβ3KO) with consequent inhibition of sustained glial-mediated inflammation. To test this, 21- and 86-day-old Adrβ3KO mice were exposed to an 8-week multisensory stimulation (MS) protocol that comprised gustatory and olfactory stimuli of positive and negative valence; intellectual challenges to reach food; the use of hidden objects; and the presentation of food in ways that prompted foraging, which was followed by analysis of GFAP, Iba-1 and EAAT2 protein expression in the hippocampus (HC) and amygdala (AMY). The MS protocol reduced GFAP and Iba-1 expression in the HC of young mice but not in older mice. While this protocol restored memory impairment when applied to Adrβ3KO animals immediately after weaning, it had no effect when applied to adult animals. In fact, we observed that aging worsened the memory of Adrβ3KO mice. In the AMY of Adrβ3KO older mice, we observed an increase in GFAP and EAAT2 expression when compared to wild-type (WT) mice that MS was unable to reduce. These results suggest that a richer and more diverse environment helps to correct memory impairment when applied immediately after weaning in Adrβ3KO animals and indicates that the control of neuroinflammation mediates this response.

11 August 2022 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
AMAndréa V. Maglione
Andréa V. Maglione
BNBruna P. P. Do Nascimento
Bruna P. P. Do Nascimento
MRMiriam O Ribeiro
Miriam O Ribeiro
TSTalytha J. L. de Souza
Talytha J. L. de Souza
RSRenata E. C. da Silva
Renata E. C. da Silva
GGGisele Giannocco
Gisele Giannocco

8 July 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
FLFernanda B. Lorena
Fernanda B. Lorena
JSJuliana M. Sato
Juliana M. Sato
BCBeatriz Martin Coviello
Beatriz Martin Coviello
AAAlexandre J. T. Arnold
Alexandre J. T. Arnold
ABAlice Batistuzzo
Alice Batistuzzo
MRMiriam O Ribeiro
Miriam O Ribeiro
The Thr92Ala-Dio2 polymorphism has been associated with reduced cognition in 2-month-old male mice and increased risk for cognitive impairment and Alzheimer’s disease in African Americans. This has been attributed to reduced thyroid hormone (TH) signaling and endoplasmic reticulum (ER) stress in the brain. Here we studied the Thr92Ala-Dio2 mouse model and saw that older male mice (7–8-month-old) exhibited a more severe cognition impairment, which extended to different aspects of declarative and working memories. A similar phenotype was observed in 4–5-month-old female mice. There were no structural alterations in the prefrontal cortex (PFC) and hippocampus of the Thr92Ala-Dio2 mouse. Nonetheless, in both male and female PFC, there was an enrichment in genes associated with TH-dependent processes, ER stress, and Golgi apparatus, while in the hippocampus there was additional enrichment in genes associated with inflammation and apoptosis. Reduced TH signaling remains a key mechanism of disease given that short-term treatment with L-T3 rescued the cognitive phenotype observed in males and females. We conclude that in mice, age is an additional risk factor for cognitive impairment associated with the Thr92Ala-Dio2 polymorphism. In addition to reduced TH signaling, ER-stress, and involvement of the Golgi apparatus, hippocampal inflammation and apoptosis were identified as potentially important mechanisms of a disease.

2 February 2022 in Research Square
Verified
Preprint
Open access
PDF file
AMAndrea Maglione
Andrea Maglione
BNBruna Nascimento
Bruna Nascimento
MRMiriam O Ribeiro
Miriam O Ribeiro
TSTalytha Souza
Talytha Souza
RSRenata Silva
Renata Silva
GGGisele Giannocco
Gisele Giannocco
Introduction: Alzheimer disease’s (AD) is a neurodegenerative disorder and it is known that the central nervous system (CNS) is an important target of thyroid hormones (TH). Moreover, an inverse association between serum triiodothyronine (T3) levels and the risk of AD was reported. Aim: To evaluate the effects of T3 treatment on the depression-like behavior observed in male transgenic 3xTg-AD mice. Main methods: Animals were divided into 2 groups, one group received daily intraperitoneal injections of L-T3 (T3 group), and the other received an equivalent volume of 0.9% saline (Control group). The experimental protocol lasted 21 days, and behavioral tests were conducted on days 15-19. At the conclusion of the experiment, the TH profile and hippocampal gene expression were evaluated. Key findings: It was observed that the T3-treated group presented significantly increased serum T3 and decreased thyroxine (T4) levels. When compared to control hippocampal samples, the T3 group exhibited attenuated glycogen synthase kinase-3 (GSK3), metalloproteinase 10 (ADAM10), amyloid-beta precursor-protein (APP), serotonin transporter (SERT), 5HT1a receptor, monocarboxylate transporter 8 (MCT8) and bone morphogenetic protein 7 (BMP-7) gene expression levels and augmented superoxide dismutase 2 (SOD2) and Hairless gene expression levels. Additionally, T3-treated animals displayed reduced immobility time in both the tail suspension and forced swim tests, and in the latter presented a higher latency time when compared to the control group. Significance: Taken together, our results demonstrate that in an AD mouse model, T3 supplementation promotes improvements in depression-like behavior, likely through the modulation of the serotonergic pathway, and also attenuated disease progression.